This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Yeda Research and Develpment & Co. Ltd, University of Washington. Active years: 2014-2020.
Company Filing History:
2 out of 1,168 
1 out of 2,166 
Years Active: 2014-2020
Title: The Innovations of Moshe Goldsmith
Introduction
Moshe Goldsmith is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides that address organophosphate exposure. With a total of 2 patents, Goldsmith's work is pivotal in advancing treatments for chemical exposure.
Latest Patents
Goldsmith's latest patents include the development of isolated phosphotriesterase polypeptides and polynucleotides encoding the same. This genetically modified polypeptide exhibits at least twice the catalytic efficiency for a V-type nerve agent compared to the standard sequence. Another significant patent involves isolated PON1 polypeptides, which demonstrate a catalytic efficiency for G-type organophosphates, providing potential therapeutic applications in preventing organophosphate exposure-related damage.
Career Highlights
Throughout his career, Goldsmith has worked with esteemed organizations such as Yeda Research and Development Company Ltd and the University of Washington. His research has focused on creating innovative solutions to mitigate the effects of harmful chemical agents.
Collaborations
Goldsmith has collaborated with prominent scientists, including Yaacov Ashani and Dan S Tawfik, enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Moshe Goldsmith's contributions to the field of biochemistry through his patents and collaborations highlight his commitment to innovation and public health. His work continues to pave the way for advancements in treating organophosphate exposure.